National Health Investors Stock Analysis

National Stock Analysis Notes

About 64.0% of the company shares are owned by institutional investors. The book value of National Health was now reported as 33.73. The company has Price/Earnings To Growth (PEG) ratio of 1.99. National Health Investors last dividend was issued on the 27th of March 2024. is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHIs portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. National Health operates under REITHealthcare Facilities classification in the United States and is traded on New York Stock Exchange. It employs 19 people. To find out more about National Health Investors contact Eric Mendelsohn at 615 890 9100 or learn more at https://www.nhireit.com.

National Health Investors Investment Alerts

National Health Investors Upcoming and Recent Events

National Largest EPS Surprises

View All Earnings Estimates

National Health Thematic Classifications

National Stock Institutional Investors

Note, although National Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

National Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 2.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate National Health's market, we take the total number of its shares issued and multiply it by National Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

National Profitablity

The company has Net Profit Margin of 0.42 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.63 %, which entails that for every 100 dollars of revenue, it generated $0.63 of operating income.

Management Efficiency

National Health Investors has Return on Asset of 0.0448 % which means that on every $100 spent on assets, it made $0.0448 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1048 %, implying that it generated $0.1048 on every 100 dollars invested. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.000008. As of now, National Health's Asset Turnover is increasing as compared to previous years.

Technical Drivers

As of the 19th of April, National Health secures the Mean Deviation of 1.14, downside deviation of 1.56, and Risk Adjusted Performance of 0.0792. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of National Health Investors, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for National Health, which can be compared to its peers in the industry. Please verify National Health Investors information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if National Health Investors is priced some-what accurately, providing market reflects its recent price of 60.44 per share. Given that National Health Investors has jensen alpha of 0.1485, we recommend you to check National Health's last-minute market performance to make sure the company can sustain itself at a future point.

National Health Investors Price Movement Analysis

National Health Investors Insider Trading Activities

National Health Outstanding Bonds

National Health Predictive Daily Indicators

National Health Corporate Filings

National Health Forecast Models

National Health's time-series forecasting models are one of many National Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary National Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how National Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling National shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as National Health. By using and applying National Stock analysis, traders can create a robust methodology for identifying National entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. National analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. National analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

National Health Investors stock analysis indicators help investors evaluate how National Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading National Health shares will generate the highest return on investment. By understating and applying National Health stock analysis, traders can identify National Health position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.

Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.